Form 4 for NEO NEOGENOMICS INC
Accepted 2023-01-04 00:00:00 ET · period of report 2023-01-01 · accession 0001077183-23-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-04 | 2023-01-01 | NEO | Harris Melody | Pres, Enterprise Ops | A - Grant | $0.00 | +108.2K | 108.2K | New | $0 |
| D | 2023-01-04 | 2023-01-01 | NEO | Harris Melody | Pres, Enterprise Ops | A - Grant | $0.00 | +201.6K | 201.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-01 | A | A | 108,225 | $0.00 | 108,225 | D | — | — | (F1) On January 1, 2023, Ms. Harris was granted 108,225 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-01-01 | A | A | 201,613 | $0.00 | 201,613 | D | $9.24 · — to 2030-01-01 | 201,613 Common Stock | (F2) On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date. |